Literature DB >> 3081924

Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.

T Archer, A Fredriksson, G Jonsson, T Lewander, A K Mohammed, S B Ross, U Söderberg.   

Abstract

The effects of noradrenaline (NA) depletion upon amphetamine-induced hyperactivity were examined in five experiments. Central NA depletion via either systemic DSP4 or neonatal 6-OHDA antagonised the amphetamine-induced (2 mg/kg SC) increase in rearing behaviour, whereas lesions of the dorsal noradrenergic bundle using 6-hydroxydopamine antagonised the increase in locomotor activity. Peripheral NA depletion following systemic 6-hydroxydopamine to adult rats did not cause any changes in motor activity after acute amphetamine administration. Desipramine, the selective NA uptake inhibitor, blocked the effects of DSP4 upon amphetamine-induced rearing. NA depletion antagonised hyperactivity produced by the 2 mg/kg dose of amphetamine, but not the hyperactivity (rearing or locomotion) effects of amphetamine at 1, 4 or 8 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081924     DOI: 10.1007/bf00652230

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Learning in the absence of forebrain noradrenaline.

Authors:  S T Mason; S D Iversen
Journal:  Nature       Date:  1975-12-04       Impact factor: 49.962

2.  Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.

Authors:  P F Von Voigtlander; K E Moore
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

3.  Possible functional differentiation between the stores from which adrenergic nerve stimulation, tyramine and amphetamine release noradrenaline.

Authors:  H O Obianwu
Journal:  Acta Physiol Scand       Date:  1969 Jan-Feb

Review 4.  Noradrenaline in the brain: progress in theories of behavioural function.

Authors:  S T Mason
Journal:  Prog Neurobiol       Date:  1981       Impact factor: 11.685

5.  Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.

Authors:  J Jonsson; T Lewander
Journal:  J Pharm Pharmacol       Date:  1974-11       Impact factor: 3.765

6.  DSP-4: a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats.

Authors:  G Jaim-Etcheverry; L M Zieher
Journal:  Brain Res       Date:  1980-04-28       Impact factor: 3.252

7.  The pharmacological and anatomical substrates of the amphetamine response in the rat.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

8.  Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat.

Authors:  S O Ogren; T Archer; C Johansson
Journal:  Neurosci Lett       Date:  1983-12-30       Impact factor: 3.046

9.  Altered hindlimb extension in the rat after DSP-4: a useful marker of central noradrenergic depletion.

Authors:  E Mogilnicka; D J Dooley; C G Boissard; A Delini-Stula
Journal:  Eur J Pharmacol       Date:  1983-02-18       Impact factor: 4.432

10.  DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.

Authors:  G Jonsson; H Hallman; F Ponzio; S Ross
Journal:  Eur J Pharmacol       Date:  1981-06-19       Impact factor: 4.432

View more
  44 in total

1.  Neurobehavioural deficits following postnatal iron overload: I spontaneous motor activity.

Authors:  A Fredriksson; N Schröder; T Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

2.  Physical exercise attenuates MPTP-induced deficits in mice.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2010-03-19       Impact factor: 3.911

3.  Delayed exercise-induced functional and neurochemical partial restoration following MPTP.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2011-08-10       Impact factor: 3.911

4.  Influence of noradrenaline denervation on MPTP-induced deficits in mice.

Authors:  T Archer; A Fredriksson
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

5.  Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice.

Authors:  A Fredriksson; C Gentsch; T Archer
Journal:  J Neural Transm Gen Sect       Date:  1994

6.  The alpha2-adrenoceptor antagonist atipamezole reduces the development and expression of d-amphetamine-induced behavioural sensitization.

Authors:  Juuso Juhila; Antti Haapalinna; Jouni Sirviö; Jukka Sallinen; Aapo Honkanen; Esa R Korpi; Mika Scheinin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-14       Impact factor: 3.000

Review 7.  Pharmacological models of ADHD.

Authors:  R M Kostrzewa; J P Kostrzewa; R A Kostrzewa; P Nowak; R Brus
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

8.  Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice II: interactions with apomorphine.

Authors:  A Fredriksson; T Archer
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

9.  Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice I: dose-, time- and parameter-dependency.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

Review 10.  Norepinephrine and stimulant addiction.

Authors:  Mehmet Sofuoglu; R Andrew Sewell
Journal:  Addict Biol       Date:  2008-09-22       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.